Compounds > 2,2',4,4'-tetrabromodiphenyl ether
Page last updated: 2024-08-26

2,2',4,4'-tetrabromodiphenyl ether and Kidney Diseases

2,2',4,4'-tetrabromodiphenyl ether has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, J; Shan, Q; Zhang, Y; Zhang, Z; Zheng, G; Zheng, Y; Zhuang, J1

Other Studies

1 other study(ies) available for 2,2',4,4'-tetrabromodiphenyl ether and Kidney Diseases

ArticleYear
Troxerutin Reduces Kidney Damage against BDE-47-Induced Apoptosis via Inhibiting NOX2 Activity and Increasing Nrf2 Activity.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Animals; Anticoagulants; Apoptosis; Halogenated Diphenyl Ethers; Hydroxyethylrutoside; Kidney; Kidney Diseases; Male; Mice; NF-E2-Related Factor 2

2017